Subscribe to RSS
DOI: 10.1055/s-0030-1249096
© Georg Thieme Verlag KG Stuttgart · New York
Transitions from General Practitioner to Psychiatrist Care (or vice versa) during a First Antidepressant Treatment Episode
Publication History
received 03.08.2009
revised 13.01.2010
accepted 22.01.2010
Publication Date:
18 May 2010 (online)

Abstract
Introduction: The aim of this study was to investigate how frequently patients transit from general practitioner (GP) to psychiatrist care and vice versa during a first antidepressant episode and antidepressant treatment changes associated with those transitions.
Method: Antidepressant episodes were constructed for patients (≥18 years) initiating SSRI use in 2000 (N=10 158). Transition in care within a first treatment episode was investigated. Changes in antidepressant treatment were compared between transiting and non-transiting patients.
Results: 6.0% of patients who initiate SSRI use in GP practice transited to psychiatrist care, whereas 39.1% of those initiating use in psychiatrist care transited to GP care. Patients transiting from GP to psychiatrist care were more likely to switch to other antidepressants (RR=6.16, 95% CI: 4.90, 7.75) or to other doses (RR=4.48, 95% CI: 3.76, 5.34) than non-transiting patients. No significant differences in antidepressant treatment were found for patients transiting from psychiatric to GP care.
Discussion: Approximately 9% of SSRI initiators transit in care. Transitions from GP to psychiatric care lead to antidepressant treatment changes and could potentially be used in observational studies as a disease severity indicator.
References
- 1 Anatomical Therapeutic Chemical (ATC) . Classification Index 2009. WHO Collaborating Centre for Drug Statistics Methodology. [cited 1 April 2009]. Available from: http://www.whocc.no/
- 2 Anon . Multidisciplinary Guidelines for Depression – guidelines for diagnosis and treatment of adult patients suffering from depression [Multidisciplinaire Richtlijk Depressie]. [cited 8 May 2009]. Available from: http://www.nvvp.net/nvvppublic/producten.ashx
- 3 Bijl D, Van Sonderen E, Haaijer-Ruskamp FM. Prescription changes and drug costs at the interface between primary and specialist care. Eur J Clin Pharmacol. 1998; 54 333-336
- 4 Buurma H, Bouvy ML, De Smet PA. et al . Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008; 33 17-23
- 5 Cochrane RA, Mandal AR, Ledger-Scott M. et al . Changes in drug treatment after discharge from hospital in geriatric patients. BMJ. 1992; 305 694-696
- 6 Cooper-Patrick L, Crum RM, Ford DE. Characteristics of patients with major depression who received care in general medical and specialty mental health settings. Med Care. 1994; 32 15-24
- 7 Gardarsdottir H, Egberts AC, van Dijk L. et al . An algorithm to identify antidepressant users with a diagnosis of depression from prescription data. Pharmacoepidemiol Drug Saf. 2009; 18 7-15
- 8 Gardarsdottir H, Heerdink ER, Egberts AC. Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands. Pharmacoepidemiol Drug Saf. 2006; 15 338-343
- 9 Gardarsdottir H, Souverein PC, Egberts AC. et al . Construction of drug treatment episodes from drug dispensing histories is influenced by the gap-length. J Clin Epidemiol. 2009 Oct 30; [Epub ahead of print]
- 10 Gaynes BN, Rush AJ, Trivedi M. et al . A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial. Gen Hosp Psychiatry. 2005; 27 87-96
- 11 Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care – a large-scale follow-up study. Eur J Clin Pharmacol. 2007; 63 783-790
- 12 Herings RM, Bakker A, Stricker BH. et al . Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health. 1992; 46 136-140
- 13 Kendrick T, Dowrick C, McBride A. et al . Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ. 2009; 338 b750
- 14 Simon GE, Von Korff M, Rutter CM. et al . Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry. 2001; 58 395-401
- 15 Stuffken R, Heerdink ER, de Koning FH. et al . Association between hospitalization and discontinuity of medication therapy used in the community setting in the Netherlands. Ann Pharmacother. 2008; 42 933-939
- 16 van Geffen EC, Gardarsdottir H, van Hulten R. et al . Initiation of antidepressant therapy: do patients follow the GP's prescription?. Br J Gen Pract. 2009; 59 81-87
Correspondence
Dr. E. R. Heerdink
Division of Pharmacoepidemiology
and Pharmacotherapy
Utrecht Institute for
Pharmaceutical Sciences
Faculty of Science
Utrecht University
PO Box 80.082
3508 TB Utrecht
The Netherlands
Phone: + 31-30-2537324
Fax: + 31-30-2539166
Email: E.R.Heerdink@uu.nl